Latest Biopharmaceutical Commercialization News

Page 1 of 1

Clinuvel Advances with 8% Revenue Growth and Vitiligo Phase III Milestone

Clinuvel Pharmaceuticals reports steady financial growth with an 8% rise in revenue and 2% profit increase, while expanding its US commercial footprint and completing recruitment for a pivotal vitiligo trial.

Ada Torres

28 Aug 2025

Browse the archive

Full archive

Aug 2026 July 2026 June 2026 May 2026 Apr 2026 Mar 2026 Feb 2026 Jan 2026